Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Du et al
Ginkgo Bioworks Sector: Biotechnology and synthetic biology HQ: The Innovation and Design Building at 27 Drydock Ave, Boston, MA Year Founded: 2008 Key Leaders: Jason Kelly, Co-Founder and CEO Number of Employees: 800900 Stage: Public Financial Snapshot: $709.80 million market cap Notable Investors: Viking Global Investors, General Atlantic, and Cascade Investment Key Products: Ginkgo Bioworks operates a cell programming platform that engineers microbes and cells to produce pharmaceuticals and other products, such as chemicals and food ingredients
This is more likely when Janumet is taken with other diabetes drugs like insulin
No, GLP-1 receptor agonists are not licensed or recommended for treating high cortisol levels or Cushing's syndrome
Consider discontinuation of estradiol treatment if pancreatitis occurs
US$ 23.51
US$ 20.09
US$ 28.55
US$ 20.77
US$ 27.43
